TickerFacts.

Universe Pharmaceuticals Inc (UPC): Operating Income

Annual figures by period end, from SEC filings.

Figures out of scale. In this company's filings, reported revenue for the year ended 2023-09-30 is more than 100 times total assets. That usually means a value was tagged in the wrong unit. Figures are shown as filed; growth rates are not computed, and the company is left out of screens and comparisons.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-09-30 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$2.92B
Year ended 2025-09-30. As filed; likely tagged in the wrong unit
$13.59M2019-09-30: $9.75M2020-09-30: $10.25M2021-09-30: $13.59M2022-09-30: -$7.02M2023-09-30: -$3.97B2024-09-30: -$8.02B2025-09-30: -$2.92B-$2.92B
2019-09-30 Operating Income (USD) 2025-09-30
Period endedOperating IncomeChange YoYSource filing
2025-09-30-$2.92Bn/a2026-01-29, From 2024-10-01
2024-09-30-$8.02Bn/a2026-01-29, From 2023-10-01
2023-09-30-$3.97Bn/a2026-01-29, From 2022-10-01
2022-09-30-$7.02Mn/a2025-04-29, From 2021-10-01
2021-09-30$13.59Mn/a2024-01-30, From 2020-10-01
2020-09-30$10.25Mn/a2022-01-31, From 2019-10-01
2019-09-30$9.75Mn/a2022-01-31, From 2018-10-01